Zhu Chen

2.0k total citations · 1 hit paper
44 papers, 1.4k citations indexed

About

Zhu Chen is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Zhu Chen has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 21 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Zhu Chen's work include Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (7 papers). Zhu Chen is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (7 papers). Zhu Chen collaborates with scholars based in China, Germany and France. Zhu Chen's co-authors include Aline Bözec, Georg Schett, Andreas Ramming, Xiang-Pei Li, Yi Qin, Yuanyuan Zhang, Wei Huang, Xiaomei Li, Yujing Li and Yaochao Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Zhu Chen

41 papers receiving 1.4k citations

Hit Papers

Anti-inflammatory and immune-regulatory cytokines in rheu... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers

Zhu Chen
Ke Jin China
Xuekun Fu China
Li Teng China
Darren L. Asquith United Kingdom
Allen N. Sapadin United States
Zhu Chen
Citations per year, relative to Zhu Chen Zhu Chen (= 1×) peers Jiajun Liu

Countries citing papers authored by Zhu Chen

Since Specialization
Citations

This map shows the geographic impact of Zhu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhu Chen more than expected).

Fields of papers citing papers by Zhu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhu Chen. The network helps show where Zhu Chen may publish in the future.

Co-authorship network of co-authors of Zhu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhu Chen. A scholar is included among the top collaborators of Zhu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhu Chen. Zhu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Ning, Tengfei Ma, Wenzhi Wang, et al.. (2024). Carbon monoxide (CO)-releasing micelles enable efficient treatment of MRSA-induced septic arthritis and rheumatoid arthritis. Nano Today. 57. 102389–102389. 8 indexed citations
3.
Wang, Xinming, Huihui Wang, Wenming Hong, et al.. (2024). Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis. Arthritis & Rheumatology. 76(6). 845–856. 9 indexed citations
4.
Cai, Minglong, Xin Wang, Zhijun Li, et al.. (2024). Effectiveness and safety of Belimumab and Telitacicept in systemic lupus erythematosus: a real-world, retrospective, observational study. Clinical Rheumatology. 44(1). 247–256. 3 indexed citations
5.
Li, Yujing, Xin Wang, Zhijun Li, et al.. (2023). Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study. Lupus Science & Medicine. 10(2). e001074–e001074. 21 indexed citations
6.
Chen, Kun, Xi Chen, Chuandong Lang, et al.. (2023). CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex. Experimental & Molecular Medicine. 55(9). 2051–2066. 16 indexed citations
7.
Huang, Wei, Hao Tang, Yang Liu, et al.. (2023). ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-κB signaling pathway. International Immunopharmacology. 121. 110433–110433. 10 indexed citations
8.
Wang, Wentao, Xin Liu, Wei Huang, et al.. (2023). Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduction and Targeted Therapy. 8(1). 202–202. 74 indexed citations
9.
Li, Zhenyu, et al.. (2023). Age/autoimmunity-associated B cells in inflammatory arthritis: An emerging therapeutic target. Frontiers in Immunology. 14. 1103307–1103307. 20 indexed citations
10.
Xiang, Nan, Xuan Fang, Xiaoge Sun, et al.. (2021). Expression profile of PU.1 in CD4+T cells from patients with systemic lupus erythematosus. Clinical and Experimental Medicine. 21(4). 621–632. 6 indexed citations
11.
Zhang, Yuanyuan, et al.. (2020). Innate lymphoid cells in inflammatory arthritis. Arthritis Research & Therapy. 22(1). 25–25. 30 indexed citations
12.
Huang, Wei, Linlin Zhang, Chao Cheng, et al.. (2019). Parallel comparison of fibroblast-like synoviocytes from the surgically removed hyperplastic synovial tissues of rheumatoid arthritis and osteoarthritis patients. BMC Musculoskeletal Disorders. 20(1). 591–591. 18 indexed citations
13.
Li, Meng, et al.. (2019). Abnormal thyroid hormone receptor signaling in osteoarthritic osteoblasts regulates microangiogenesis in subchondral bone. Life Sciences. 239. 116975–116975. 13 indexed citations
14.
Zhou, Yan, Ping Liu, Chunhui Xu, et al.. (2018). Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation. Cell Research. 28(4). 476–490. 46 indexed citations
15.
Li, Jin, Hong Zhang, Xuan Fang, et al.. (2016). Clinical and immunological consequences of total glucosides of paeony treatment in Sjögren's syndrome: A randomized controlled pilot trial. International Immunopharmacology. 39. 314–319. 25 indexed citations
16.
Sun, Xiaoge, Jin‐Hui Tao, Nan Xiang, et al.. (2016). Negative Correlation Between miR-326 and Ets-1 in Regulatory T Cells from new-Onset SLE Patients. Inflammation. 39(2). 822–829. 34 indexed citations
17.
Xiang, Nan, Xiaomei Li, Dongbao Zhao, et al.. (2015). Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis. International Immunopharmacology. 28(1). 802–807. 43 indexed citations
18.
Yu, Ning, Xiang-Pei Li, Li Wang, et al.. (2014). Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus. International Journal of Rheumatic Diseases. 19(2). 199–204. 11 indexed citations
19.
Chen, Zhu, Guosheng Wang, Guihong Wang, & Xiang-Pei Li. (2012). Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis. Clinical Rheumatology. 31(9). 1323–1329. 26 indexed citations
20.
Chen, Zhu, Pascale Loiseau, Jean Christophe Bories, Armand Bensussan, & François Sigaux. (1989). Rearranging sequence located in the intron of the human T cell receptor γ chain gene constant region. European Journal of Immunology. 19(4). 637–642. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026